A blind, prospective, randomized, controlled trial was conducted to as
sess the analgesic properties of intraarticular bupivacaine after day-
case arthroscopy. Forty-eight patients undergoing routine arthroscopy
were randomly allocated to receive 10 ml of 0.5% bupivacaine or 0.9% s
aline into the joint at the end of the procedure. The analgesic effect
s were assessed by visual analogue scales at discharge, on going to be
d, and the following morning. Significant reduction in reported pain w
as found in the treatment groups on leaving the hospital and later the
same evening, although no benefit was found the following day.